These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35046461)

  • 1. Construction of SARS-CoV-2 virus-like particles in plant.
    Moon KB; Jeon JH; Choi H; Park JS; Park SJ; Lee HJ; Park JM; Cho HS; Moon JS; Oh H; Kang S; Mason HS; Kwon SY; Kim HS
    Sci Rep; 2022 Jan; 12(1):1005. PubMed ID: 35046461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, production and characterization of SARS-CoV-2 virus-like particles (Coronaviridae:
    Latyshev OE; Zaykova ON; Eliseeva OV; Savochkina TE; Chernoryzh YY; Syroeshkin AV; Petrov GV; Vorkunova GK; Larichev VF; Fediakina IT; Cherepushkin SA; Tsibezov VV; Yuzhakova KA; Kulikova NY; Lebedeva VV; Yakunin DY; Kozlova AA; Baranets MS; Yurlov KI; Lesnova EI; Grebennikova TV
    Vopr Virusol; 2024 May; 69(2):175-186. PubMed ID: 38843023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunodominant and neutralization linear epitopes for SARS-CoV-2.
    Lu S; Xie XX; Zhao L; Wang B; Zhu J; Yang TR; Yang GW; Ji M; Lv CP; Xue J; Dai EH; Fu XM; Liu DQ; Zhang L; Hou SJ; Yu XL; Wang YL; Gao HX; Shi XH; Ke CW; Ke BX; Jiang CG; Liu RT
    Cell Rep; 2021 Jan; 34(4):108666. PubMed ID: 33503420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients.
    Smits VAJ; Hernández-Carralero E; Paz-Cabrera MC; Cabrera E; Hernández-Reyes Y; Hernández-Fernaud JR; Gillespie DA; Salido E; Hernández-Porto M; Freire R
    Biochem Biophys Res Commun; 2021 Mar; 543():45-49. PubMed ID: 33515911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2.
    Dangi T; Class J; Palacio N; Richner JM; Penaloza MacMaster P
    Cell Rep; 2021 Sep; 36(10):109664. PubMed ID: 34450033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.
    Oliveira SC; de Magalhães MTQ; Homan EJ
    Front Immunol; 2020; 11():587615. PubMed ID: 33193414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An integrated in silico immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targets.
    Ward D; Higgins M; Phelan JE; Hibberd ML; Campino S; Clark TG
    Genome Med; 2021 Jan; 13(1):4. PubMed ID: 33413610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.
    Uttamrao PP; Sathyaseelan C; Patro LPP; Rathinavelan T
    Front Immunol; 2021; 12():692937. PubMed ID: 34497604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation.
    Bai Z; Cao Y; Liu W; Li J
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34200602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do preexisting antibodies against seasonal coronaviruses have a protective role against SARS-CoV-2 infections and impact on COVID-19 severity?
    Nasrallah GK
    EBioMedicine; 2022 Feb; 76():103831. PubMed ID: 35081490
    [No Abstract]   [Full Text] [Related]  

  • 12. An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages.
    Motamedi H; Ari MM; Dashtbin S; Fathollahi M; Hossainpour H; Alvandi A; Moradi J; Abiri R
    Int Immunopharmacol; 2021 Jul; 96():107763. PubMed ID: 34162141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA Vaccines Expressing the Envelope and Membrane Proteins Provide Partial Protection Against SARS-CoV-2 in Mice.
    Chen J; Deng Y; Huang B; Han D; Wang W; Huang M; Zhai C; Zhao Z; Yang R; Zhao Y; Wang W; Zhai D; Tan W
    Front Immunol; 2022; 13():827605. PubMed ID: 35281016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Integrated Platform for Serological Detection and Vaccination of COVID-19.
    Wei SC; Hsu WT; Chiu CH; Chang FY; Lo HR; Liao CY; Yang HI; Chou YC; Tsai CH; Chao YC
    Front Immunol; 2021; 12():771011. PubMed ID: 35003088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
    Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
    Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
    Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
    Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in virus-like particle-based SARS-CoV-2 vaccines.
    Hao X; Yuan F; Yao X
    Front Cell Infect Microbiol; 2024; 14():1406091. PubMed ID: 38988812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
    Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates.
    Hong SH; Oh H; Park YW; Kwak HW; Oh EY; Park HJ; Kang KW; Kim G; Koo BS; Hwang EH; Baek SH; Park HJ; Lee YS; Bang YJ; Kim JY; Bae SH; Lee SJ; Seo KW; Kim H; Kwon T; Kim JH; Lee S; Kim E; Kim Y; Park JH; Park SI; Gonçalves M; Weon BM; Jeong H; Nam KT; Hwang KA; Kim J; Kim H; Lee SM; Hong JJ; Nam JH
    Sci Adv; 2021 May; 7(22):. PubMed ID: 34049881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization.
    Chiba S; Frey SJ; Halfmann PJ; Kuroda M; Maemura T; Yang JE; Wright ER; Kawaoka Y; Kane RS
    Commun Biol; 2021 May; 4(1):597. PubMed ID: 34011948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.